Hassan Fred 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Hassan Fred
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-03+40,000→ 40,000 totalExercise: $8.26From: 2026-01-03Exp: 2035-01-03→ Common Stock (40,000 underlying)